Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Shryock

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2004
Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndromeLin Wu, John C Shryock, Yejia Song, et al.
Journal of Molecular and Cellular Cardiology|May 9, 2008
Late sodium current inhibition as a new cardioprotective approachSharon L Hale, John C Shryock, Luiz Belardinelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 14, 2009
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heartLin Wu, Sridharan Rajamani, Hong Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2007
Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acidArvinder K Dhalla, Melissa Santikul, Michelle Smith, et al.
Cardiovascular Research|November 17, 2007
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodaroneLin Wu, Sridharan Rajamani, John C Shryock, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 3, 2011
Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogsGong Zhao, Suhua Zhang, John C Shryock, et al.
Journal of Cardiovascular Pharmacology|April 8, 2014
Ranolazine attenuates hypoxia- and hydrogen peroxide-induced increases in sodium channel late openings in ventricular myocytesJihua Ma, Yejia Song, John C Shryock, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2011
Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabainKirsten Hoyer, Yejia Song, Desuo Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 22, 2009
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusionArvinder K Dhalla, Wei-Qun Wang, Joan Dow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
A novel partial agonist of the A(1)-adenosine receptor and evidence of receptor homogeneity in adipocytesMarjan Fatholahi, Yiwen Xiang, Yuzhi Wu, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|March 20, 2004
Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndromeLin Wu, John C Shryock, Yejia Song, et al.
Journal of Molecular and Cellular Cardiology|May 9, 2008
Late sodium current inhibition as a new cardioprotective approachSharon L Hale, John C Shryock, Luiz Belardinelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 14, 2009
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heartLin Wu, Sridharan Rajamani, Hong Li, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2007
Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acidArvinder K Dhalla, Melissa Santikul, Michelle Smith, et al.
Cardiovascular Research|November 17, 2007
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodaroneLin Wu, Sridharan Rajamani, John C Shryock, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 3, 2011
Selective action of metoprolol to attenuate regadenoson-induced tachycardia in conscious dogsGong Zhao, Suhua Zhang, John C Shryock, et al.
Journal of Cardiovascular Pharmacology|April 8, 2014
Ranolazine attenuates hypoxia- and hydrogen peroxide-induced increases in sodium channel late openings in ventricular myocytesJihua Ma, Yejia Song, John C Shryock, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2011
Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabainKirsten Hoyer, Yejia Song, Desuo Wang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 22, 2009
Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusionArvinder K Dhalla, Wei-Qun Wang, Joan Dow, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
A novel partial agonist of the A(1)-adenosine receptor and evidence of receptor homogeneity in adipocytesMarjan Fatholahi, Yiwen Xiang, Yuzhi Wu, et al.
Pageof 6